Accelerating real‐world prediction and research in Alzheimer's: The M3AD study
Alzheimer's & Dementia · 2026-03 · 22 (3)
DOI: 10.1002/alz.71174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 18.03.2026. Verfasst von Moïse Desvarieux und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Electronic Health Records. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Chronic diseases, including Alzheimer's disease (AD) and related dementia (ADRD), do not exist solely as isolated entities. Instead, they weave concomitant trajectories of multiple diseases, conditions, behaviors, and risks, mutually influencing each other's course and natural history, in ways yet unexplored. Electronic health records (EHRs) provide us with a unique opportunity to look at related and unrelated clinical trajectories over time, thus potentially providing insight into unrecognized prodromes, while incorporating the complexities of patients' lives. We harmonize and federate a three‐city EHR metaplatform of nearly 10 million patients (∼60,000 with AD/ADRD), which we further embed within census tracts, to contextualize these health trajectories. Our multidisciplinary approach ambitions a unique dynamic platform to inform strategies to tailor risk prediction, complex clinical management, and real‐world evaluation of future treatments of AD/ADRD. We present the rationale for and design of the Multimorbidity Three‐City Alzheimer's Disease EHR (M3AD) Study and real‐world data metaplatform, progress and demonstration of feasibility, its expected singular and complementary contributions to the field. Highlights Our success in living longer lives often brings chronic conditions and multimorbidity. Alzheimer's research should comprise life trajectories’ complexity in multimorbidity. New real‐world analytical approaches allow integrated prediction of Alzheimer's disease. We are building a three‐city electronic health record (EHR) metaplatform for prediction, prevention, and impact We further embed EHR within census tracts to contextualize Alzheimer's trajectories
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
- International Associated Laboratory on Chronic Disease and Multimorbidity, Mailman School of Public Health and Centre for Research in Epidemiology and Statistics (CRESS), Université Paris Cité and Université Sorbonne Pa…
- Evelyn McKnight Brain Institute, School of Medicine, University of Miami, Miami, Florida, USA.
- Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida, USA.
- Institute for Population and Precision Health, Biological Sciences Division, University of Chicago, Chicago, Illinois, USA.
- Department of Biostatistics, Columbia University, New York, New York, USA.
Förderung
- NIA NIH HHS
- NIH HHS
- National Institute on Aging
- National Institutes of Health
Zitieren
APA
Desvarieux, M., Rundek, T., Ahsan, H., Narvaez, J., Diaz, F., Malinsky, D., Ruiz, L. M., Topaz, M., Falconer, T., Natarajan, K., Noble, J., Entwisle, B., Puram, D., Anand, T., Chen, H. Y., Jiang, X., Gu, Y., Cohen, A., Terry, M. B., …, & Hripcsak, G. (2026). Accelerating real‐world prediction and research in Alzheimer's: The M3AD study. Alzheimer's & Dementia, 22(3). https://doi.org/10.1002/alz.71174
Vancouver
Desvarieux M, Rundek T, Ahsan H, Narvaez J, Diaz F, Malinsky D, et al. Accelerating real‐world prediction and research in Alzheimer's: The M3AD study. Alzheimer's & Dementia. 2026;22(3). doi:10.1002/alz.71174
BibTeX
@article{Desvarieux2026,
author = {Desvarieux, Moïse and Rundek, Tatjana and Ahsan, Habibul and Narvaez, Javier and Diaz, Felipe and Malinsky, Daniel and Ruiz, Luis Marco and Topaz, Maxim and Falconer, Thomas and Natarajan, Karthik and Noble, James and Entwisle, Barbara and Puram, Deepthi and Anand, Tara and Chen, Hsin Yi and Jiang, Xinzhuo and Gu, Yian and Cohen, Alan and Terry, Mary Beth and Pierce, Brandon and Andrews, Howard and Rogalsky, Emily and Farzana, Shahla and Gulotta, George and Beard, John and Landron, Danielle and Volchenboum, Samuel L and Ravaud, Philippe and Johnson, Julie and Susser, Ezra and Rundle, Andrew and Wei, Ying and Tsinoremas, Nick and Loewenstein, David and Fried, Linda and Aiello, Allison and Mayeux, Richard and Hripcsak, George},
title = {Accelerating real‐world prediction and research in Alzheimer's: The M3AD study},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {3},
doi = {10.1002/alz.71174}
}
EUVIMED